Latest Regulatory Progress News

DPM Metals has revealed a major new gold-copper porphyry discovery at its Brevene South Porphyry target adjacent to the Chelopech mine, with drill results showing broad intervals of high-grade mineralization and plans for an intensive follow-up drilling campaign.

Sky Metals has secured a crucial regulatory milestone for its Tallebung tin-silver-tungsten project in NSW, moving into the Environmental Impact Statement phase following the issuance of SEARs by the NSW Department of Planning. The company prepares for imminent resource and feasibility updates that could shape the project’s development trajectory.

Iron Bear Resources has applied for its Labrador Trough iron ore project to be designated a Project of National Significance under Canada's new Building Canada Act, aiming to fast-track approvals and financing.

Elsight has secured a follow-on US$2 million order from a U.S. public safety customer, quadrupling its initial purchase and underscoring growing commercial traction ahead of expected FAA drone rule changes.

TruScreen Group reported a 42% increase in FY2026 sales driven by new market entries including India and Indonesia, alongside launching a large-scale cervical cancer screening program in Vietnam and submitting major UNITAID proposals.

Immuron Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information but pointing to a recent CEO presentation as a possible driver.

Jameson Resources has cleared a major environmental hurdle for its Crown Mountain steelmaking coal project, receiving the Section 27 Notice from British Columbia regulators and setting the stage for final application submission in October 2026.

Pacgold has restarted drilling at its Vertigo deposit and begun irrigating 100,000 tonnes of re-crushed material at White Dam, aiming to accelerate production restart and resource growth.

Finder Energy is pushing ahead with its Kuda Tasi and Jahal (KTJ) oil development, lodging key regulatory approvals and progressing debt financing amid a firmer Brent oil price outlook. The company targets final investment decision by mid-2026 and aims for first oil in late 2027 or early 2028.

Neuren Pharmaceuticals reported a 15% rise in 2025 royalties from DAYBUE®, boosted by strong US sales and a new powder formulation launch. The company is progressing its pivotal Phase 3 trial for NNZ-2591 in Phelan-McDermid syndrome and reassessing capital management amid solid cash reserves.

Memphasys has landed a major 1,000-cartridge order for its Felix™ System from MENA distributor ITL, with strong repeat demand from Qatar’s Hamad Medical Corporation and new market expansions into UAE, Kuwait, and soon Turkey.

Aguia Resources has received official commercialisation approval for its Pampafos phosphate fertiliser project, enabling invoicing and marketing ahead of a targeted sales campaign designed to boost cash flow by mid-2026.